You are here

Global Airway Stent/Lung Stent Market to 2024: Tracheobronchial Stents Segment is Projected to Witness the Highest Growth

DUBLIN, July 2, 2019 /PRNewswire/ -- The "Airway Stent/Lung Stent Market by Type (Tracheal, Bronchial, Laryngeal Stent), Product (Non-Expandable, Self-Expandable Stents), Material (Metal (Nitinol, Stainless Steel), Silicone, Hybrid), End User (Hospitals, ASCs) - Global Forecast to 2024" report has been added to's offering.

The Airway Stent/Lung Stent Market is Projected to Reach USD 120 Million by 2024 from USD 87 Million in 2019, at a CAGR of 6.7%.

Factors such as rise in prevalence of lung cancer, increasing incidence of chronic respiratory diseases, continuous growth in the healthcare industry, and rising preference towards minimally invasive procedures are expected to drive the growth of the airway stent/lung stent market. However, the complications associated with stents and the availability of alternative treatments are anticipated to impede the growth of this market to a certain extent.

The tracheobronchial stents segment is projected to witness the highest growth during the forecast period. 

Based on type, the airway stent/lung stent market is segmented into tracheobronchial and laryngeal stents. The tracheobronchial stents segment is projected to register the highest CAGR during the forecast period. The higher adoption of tracheal and bronchial stents in the treatment of lung cancer and other chronic respiratory diseases is driving the growth of this market.

The hybrid stents segment is expected to grow at the highest rate during the forecast period. 

Based on material, the airway stent/lung stent market is segmented into metal, nitinol, and hybrid stents. Hybrid stents are expected to grow at the highest CAGR during the forecast period. These stents eliminate the complications caused by metal or silicone airway/lung stents. Moreover, their larger application as compared to metal & silicone airway/lung stents is driving their adoption among healthcare providers. However, hybrid airway/lung stents are more expensive than other airway/lung stents. This is a major factor limiting their adoption in emerging markets.

The ambulatory surgical center's segment is expected to register the highest CAGR during the forecast period 

Based on the end user, the airway stent/lung stent market is segmented into hospitals and ambulatory surgical centers. The ambulatory surgical center's segment is projected to register the highest CAGR during the forecast period. The rising number of ambulatory surgical centers and outpatient surgeries is driving the growth of this segment.

Asia Pacific to witness the highest growth during the forecast period.

Asia Pacific is expected to witness the highest growth during the forecast period (2019 to 2024). Rapidly developing healthcare industry in China & India, growth in aging population, rising incidences of lung cancer & other chronic diseases, rising life expectancy, mounting per capita income, increasing investments by key market players, expansion of private-sector hospitals & reach of ASCs to rural areas, availability of low-cost labor, and the presence of a favorable regulatory environment are supporting the growth of the airway stent/lung stent market in the Asia Pacific.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Lung Stents Market: Market Overview
4.2 Asia Pacific: Lung Stents Market, 2018
4.3 Lung Stents Market: Geographic Growth Opportunities
4.4 Lung Stents Market: Geographic Mix
4.5 Lung Stents Market: Developing vs Developed Countries/Regions

5 Market Overview
5.1 Introduction
5.2 Market Dynamics: Impact Analysis
5.3 Market Drivers
5.3.1 Rising Prevalence of Lung Cancer and Respiratory Diseases
5.3.2 Increasing Preference for Minimally Invasive Procedures
5.3.3 Continuous Growth in the Healthcare Industry Increasing Life Expectancy Rising Healthcare Expenditure Growing Geriatric Population
5.4 Market Restraints
5.4.1 Decreasing Prevalence of Tobacco Smoking
5.4.2 Availability of Alternative Treatments
5.4.3 Complications Associated With Stents
5.5 Market Opportunities
5.5.1 Need for Customized Lung Stents
5.5.2 Development of Biodegradable and Drug-Eluting Lung Stents
5.5.3 3D Printing of Lung Stents

6 Industry Insights
6.1 Reimbursement Scenario for Airway Stenting Procedures
6.2 Regulatory Analysis
6.2.1 North America US Canada
6.2.2 Europe
6.2.3 Asia Pacific Japan China India
6.2.4 Latin America Brazil Mexico

7 Lung Stents Market, By Type
7.1 Introduction
7.2 Tracheobronchial Stents
7.2.1 Tracheobronchial Stents Dominate the Airway/Lung Stents Market
7.3 Laryngeal Stents
7.3.1 Rising Prevalence of Laryngeal Stenosis & Laryngeal Web & Atresia Will Drive the Market for Laryngeal Stents

8 Lung Stents Market, By Material
8.1 Introduction
8.2 Metal Stents
8.2.1 Nitinol Stents Nitinol Stents Segment Dominates the Metal Airway/Lung Stents Market
8.2.2 Stainless Steel Stents Stainless Steel Airway/Lung Stents Can Be Inserted Via Rigid Or Flexible Bronchoscopy
8.2.3 Other Metal Stents
8.3 Silicone Stents
8.3.1 Silicone Stents Cause Less Local Inflammatory Response, Resulting in Reduced Tissue Granulation
8.4 Hybrid Stents
8.4.1 Hybrid Airway/Lung Stents are More Expensive as Compared to Metal and Silicone Airway/Lung Stents

9 Lung Stents Market, By Product
9.1 Introduction
9.2 Self-Expandable Stents
9.2.1 Self-Expandable Stents Do Not Require Surgical Implantation
9.3 Non-Expandable Stents
9.3.1 Non-Expandable Stents are Used in the Treatment of Tracheobronchial Tumors & Tracheal Stenosis With Scarring

10 Lung Stents Market, By End User
10.1 Introduction
10.2 Hospitals
10.2.1 Rising Number of Bronchoscopy Surgical Procedures Performed in Hospitals to Drive Market Growth
10.3 Ambulatory Surgery Centers
10.3.1 Increasing Number of Outpatient Surgeries Performed at ASCs is Expected to Drive the Demand for Airway/Lung Stents at ASCs

11 Lung Stents Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US The US is the Largest Regional Market for Airway/Lung Stents
11.2.2 Canada Canada is Estimated to Grow at A Relatively Lower Rate Than the US
11.3 Europe
11.3.1 Germany Germany Holds the Largest Share in the European Market
11.3.2 UK Increasing Incidence of Chronic Respiratory Diseases and Rising Number of Tobacco Smokers, Will Drive the UK Market
11.3.3 France High Healthcare Expenditure Will Ensure Continued Market Growth in France
11.3.4 Italy The Italian Healthcare Market is Expected to Witness Low Growth Owing to the Ongoing Economic Crisis in the Country
11.3.5 Spain Large Debts and Slow Growth of the Healthcare System Will Challenge Market Growth in Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 China China Will Grow at the Highest Rate in the APAC Market
11.4.2 Japan Availability of Universal Healthcare Reimbursement Policy in Japan Supports the Adoption for Airway Stent Products
11.4.3 India India has Captured A Notable Share of the APAC Airway/Lung Stents Market
11.4.4 Rest of Asia Pacific
11.5 Latin America
11.6 Middle East & Africa

12 Competitive Landscape
12.1 Introduction
12.2 Product Portfolio Matrix
12.3 Geographical Assessment of Key Players in the Airway/Lung Stents Market (2018)
12.4 Competitive Leadership Mapping
12.4.1 Visionary Leaders
12.4.2 Innovators
12.4.3 Dynamic Differentiators
12.4.4 Emerging Companies
12.5 Airway/Lung Stents Market Leadership Analysis (2018)
12.6 Competitive Situations and Trends
12.6.1 Partnerships (2016 - 2019)
12.6.2 Distribution Agreement (2016-2019)
12.6.3 Expansions (2018 - 2019)

13 Company Profiles

  • Bess Aktiengesellschaft (Bess AG)
  • Boston Scientific Corporation
  • Cook Group
  • E. Benson Hood Laboratories, Inc.
  • Efer Endoscopy
  • Endo-Flex GmbH
  • Merit Medical Systems, Inc.
  • Micro-Tech (Nanjing) Co., Ltd.
  • Standard Sci. Tech Inc.
  • Taewoong Medical Co., Ltd.

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets